Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dan A. Chiche"'
Autor:
Andrew Griffin, Stuart Hossack, Richard L. Leff, Dan A. Chiche, Philippe Walker, Roxane Aubray, William Brown
Publikováno v:
The Journal of Pain. 18:726-738
Most previous transient receptor potential vanilloid subtype 1 (TRPV1) antagonist programs have been put on hold, mainly because of on-target adverse events: hyperthermia and impaired noxious heat sensation. NEO6860 is a TRPV1 antagonist, blocking ca
Autor:
Margit Solymár, Donald J. Kyle, Zsolt Szakács, András Garami, Robson Cristiano Lillo Vizin, Nelli Farkas, Wade D. Van Horn, Dan A. Chiche, Ram P. Kapil, Yury P. Shimansky, Zoltan Rumbus, Judit Hegyi, Andrej A. Romanovsky, Alexandra Csenkey, Péter Hegyi
Publikováno v:
Pharmacology & Therapeutics. 208:107474
Antagonists of the transient receptor potential vanilloid-1 (TRPV1) channel alter body temperature (Tb) in laboratory animals and humans: most cause hyperthermia; some produce hypothermia; and yet others have no effect. TRPV1 can be activated by caps
Autor:
Richard L. Leff, Jeffrey Miller, Philippe Walker, Pierre Arsenault, Roi Treister, Nathaniel P. Katz, William Brown, Dan A. Chiche
Publikováno v:
Pain Reports
PAIN Reports, Vol 3, Iss 6, p e696 (2018)
PAIN Reports, Vol 3, Iss 6, p e696 (2018)
Introduction:. NEO6860 is a TRPV1 antagonist when activated by capsaicin but not by heat or pH, developed to relieve pain without the adverse events reported with non–modality-selective TRPV1 antagonists. Objective:. The primary Objective of this s
Publikováno v:
The Journal of Pain. 17:S79